Adenocarcinoma - Research News and Information

Wednesday, January 07, 2009

The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.

29 Nov 2008 BACKGROUND: Human and animal studies have suggested that diet-derived flavonoids, in particular quercetin may play a beneficial role by preventing or inhibiting oncogenesis, but the underlying mechanism remains unclear. The aim of this study is to ... Read more...

Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.

29 Nov 2008 BACKGROUND: Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of various cancers and affect tumoral growth factors. METHODS: We investigated the effect of a new GHRH antagonist MZ-J-7-138 at doses of 1.25, 2.5, 5 and 10 ... Read more...

Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.

29 Nov 2008 BACKGROUND: Cell adhesion plays an important role in proliferation, metastasis, and tumor growth and may represent a potential vulnerability in treatment of prostate cancer patients. Bicalutamide (Casodex) has been used as an anti-androgen agent ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Adenocarcinoma'

These are the very latest articles for this heading:

• The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. 29 Nov 2008
• Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138. 29 Nov 2008
• Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation. 29 Nov 2008
• Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. 29 Nov 2008
• Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. 29 Nov 2008
• The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer. 29 Nov 2008
• NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. 29 Nov 2008
• A polygenic model with common variants may predict lung adenocarcinoma risk in humans. 13 Nov 2008
• Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. 13 Nov 2008
• Tumor spectrum of adult intussusception. 30 Oct 2008
• Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. 30 Oct 2008
• Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology. 30 Oct 2008
• Upregulation of GADD153 by butyrate: involvement of MAPK. 30 Oct 2008
• Do prostatic transition zone tumors have a distinct morphology? 30 Oct 2008
• Cribriform carcinoma of the gallbladder: a clinicopathologic study of 7 cases. 30 Oct 2008
• Immunohistochemical detection of carcinoma in radical prostatectomy specimens following hormone therapy. 30 Oct 2008
• Transoral robotic surgery using an image guidance system. 30 Oct 2008
• Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus. 30 Oct 2008
• Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets. 30 Oct 2008
• Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. 30 Oct 2008

See a longer list of these articles.

Technical information about 'Adenocarcinoma'

Definition: A malignant epithelial tumor with a glandular organization.

Descriptor UI: D000230

Alternative terms: Adenocarcinoma; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas; Carcinoma, Granular Cell; Carcinomas, Granular Cell; Granular Cell Carcinoma; Granular Cell Carcinomas; Adenocarcinoma, Granular Cell; Adenocarcinomas, Granular Cell; Granular Cell Adenocarcinoma; Granular Cell Adenocarcinomas; Adenocarcinoma, Tubular; Adenocarcinomas, Tubular; Tubular Adenocarcinoma; Tubular Adenocarcinomas; Carcinoma, Tubular; Carcinomas, Tubular; Tubular Carcinoma; Tubular Carcinomas; Carcinoma, Cribriform; Carcinomas, Cribriform; Cribriform Carcinoma; Cribriform Carcinomas; Adenocarcinoma, Basal Cell; Adenocarcinomas, Basal Cell; Basal Cell Adenocarcinoma; Basal Cell Adenocarcinomas; Adenocarcinoma, Oxyphilic; Adenocarcinomas, Oxyphilic; Oxyphilic Adenocarcinoma; Oxyphilic Adenocarcinomas;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.557.470.200.025;

Technical Notes: coord IM with precoord organ/neopl term (IM)